TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -2 | -2 | 2 | 3 | -5 | -22 | -4 |
| S | %wins | 100 | 50 | 50 | 50 | 100 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/6/12 19:44 | 6/5/12 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rackear Andrew D. | NJ | O | VP,GC | S | -11 | 6.81 | 1 | -2 | -3 | 57 | D | -35 | -33 | -4 | 0 | 7 | 11 | 10 | 5 | -2 | 1 | 0 | -4 | 0 | -35 |
11/10/11 17:09 | 11/10/11 | ENZN | Enzon Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Rackear Andrew D. | NJ | O | VP,GC | S | -25 | 6.68 | 1 | -4 | -7 | 48 | D | -32 | -38 | -42 | -16 | -9 | -6 | -8 | -5 | -1 | -4 | 4 | 10 | -9 | -8 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |